Takahiko Nakane

Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone

Hirohisa Nakamae, Kei Tsumura, Yoshiki Terada et al. · Cancer · 2005 · 241 citations · Full text

Clinical Factors Predicting the Response of Acute Graft-versus-Host Disease to Corticosteroid Therapy: An Analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation

Makoto Murata, Hideki Nakasone, Junya Kanda et al. · Biology of Blood and Marrow Transplantation · 2013 · 77 citations · Full text

Cell Therapy, Immunology, Immunotherapy +17

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

Yoshiki Terada, Hirohisa Nakamae, Ran Aimoto et al. · Journal of Experimental & Clinical Cancer Research · 2009 · 65 citations · Full text

Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib

Yoshiki Hayashi, Hirohisa Nakamae, Takako Katayama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 59 citations

Mixed-phenotype Acute Leukemia, Immunology, Immune Regulation +21

CXCL1–Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow–Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma

Hiroaki Kasashima, Masakazu Yashiro, Hirohisa Nakamae et al. · American Journal Of Pathology · 2016 · 48 citations · Full text

Receptor 2, Oncology, Gastrointestinal Oncology +10